Effects of LOTRIGA in chronic heart failure patients with hyperlipidemia:a prospective randomized,open-label,parallel group comparison study
Not Applicable
Recruiting
- Conditions
- chronic heart failure with hyperlipidemia
- Registration Number
- JPRN-UMIN000011468
- Lead Sponsor
- Aichi Medical University,Department of Cardiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.patients who are planned PCI or CABG 2.patients who have myocardial ischemia 3.unstable patient due to non-cardiac disease 4.pregnant woman 5.patients who are judged to be inappropriate to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a rate of change of LVEF after dosage from baseline to 12-months follow-up
- Secondary Outcome Measures
Name Time Method a rate of change of LVEF after dosage from baseline to 6-months follow-up major adverse cardiac event(cardiovascular death,non-fatal MI,UAP,hospitalization for heart failure,stroke,other cardiovascular events)